Covista (CVSA) Stock Price, News & Analysis
Company Description
Covista Inc. is a NYSE-listed healthcare education company that operates a portfolio of accredited institutions serving students preparing for healthcare and related professional careers. The company is identified in its public materials as America's largest healthcare educator and is organized around postsecondary education for fields tied to the U.S. healthcare workforce, including nursing, medicine, veterinary medicine, behavioral health and other health-related disciplines. Its common stock trades on the New York Stock Exchange under the symbol CVSA.
Covista is the parent company of five accredited institutions: American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. Through these institutions, the company provides degree programs, professional education pathways and related academic services for students pursuing healthcare careers. Its operating model combines institution-level academic brands with centralized capabilities in digital learning, marketing, innovation and employer or healthcare-system relationships.
Education platform and institutions
Chamberlain University is a core nursing and healthcare education institution within Covista's portfolio. American University of the Caribbean School of Medicine and Ross University School of Medicine support physician education, while Ross University School of Veterinary Medicine provides veterinary medical education. Walden University adds a broad online and professional education platform that includes health, behavioral health and related career pathways. Covista's news and investor materials emphasize enrollment trends, academic outcomes, student access and the alignment of graduates with healthcare workforce needs.
The company describes its education model as personalized and technology-enabled. Recent corporate materials also identify healthcare artificial intelligence education as an area of curriculum development, including AI credentials across its institutions and collaborations with technology and healthcare partners. Covista's disclosed activities include AI-focused learning content, responsible use of AI in clinical settings and programs intended to prepare learners for technology-enabled healthcare environments.
Business model and operating focus
Covista generates revenue primarily through education services provided by its institutions. Its recurring operating disclosures focus on student enrollment, institutional performance, program demand, academic outcomes, tuition-based revenue, operating income, adjusted earnings measures, share repurchases, debt refinancing and fiscal-year guidance. The company's strategy materials describe growth through capacity expansion, employer and health-system partnerships, digital learning, AI-enabled curriculum transformation and new program development.
The company's public positioning is tied to the healthcare workforce shortage in the United States. Covista materials describe demand for nurses, physicians, behavioral health professionals and other healthcare workers, and they connect the company's academic portfolio to workforce supply, residency attainment, rural healthcare access and partnerships with health systems and government-related initiatives. These themes are part of the company's durable operating narrative rather than a single product line.
Corporate identity
Covista's current public-company identity reflects a completed name-and-ticker transition under which the company began trading on the NYSE under CVSA. Its public disclosures and news releases now present Covista as the parent company of the five-institution healthcare education portfolio. The company's regulatory filings include current reports that furnish operating results, investor communications, capital allocation updates and strategic progress related to its education platform.
Stock Performance
Covista (CVSA) stock last traded at $115.84, up 0.65% from the previous close. Over the past 12 months, the stock has gained 15.6%. At a market capitalization of $3.9B, CVSA is classified as a mid-cap stock with approximately 34.0M shares outstanding.
CVSA Rankings
Latest News
Covista has 10 recent news articles, with the latest published 4 days ago. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include conferences, earnings, AI. View all CVSA news →
SEC Filings
Covista has filed 5 recent SEC filings, including 4 Form 4, 1 Form 144. The most recent filing was submitted on July 16, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CVSA SEC filings →
Insider Radar
Insider selling at Covista over the past 90 days can reflect routine portfolio management, scheduled trading plans (Rule 10b5-1), tax planning, or compensation-related dispositions rather than a directional view on the stock.
Financial Highlights
Covista generated $1.8B in revenue over the trailing twelve months, retaining a 56.9% gross margin, operating income reached $341.5M (19.1% operating margin), and net income was $237.1M, reflecting a 13.3% net profit margin. Diluted earnings per share stood at $6.18. The company generated $337.9M in operating cash flow. With a current ratio of 0.82, short-term liquidity bears monitoring.
Upcoming Events
Q4 FY2026 Results
Q4 FY2026 Conference Call
Cincinnati campus opens
Pilot AI classroom
Program classes start
BSN classes start
Covista has 6 upcoming scheduled events. The next event, "Q4 FY2026 Results", is scheduled for August 6, 2026 (in 11 days). Investors can track these dates to stay informed about potential catalysts that may affect the CVSA stock price.
Short Interest History
Short interest in Covista (CVSA) currently stands at 1.6 million shares, down 0.5% from the previous reporting period, representing 4.9% of the float. Over the past 12 months, short interest has decreased by 10.6%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Covista (CVSA) currently stands at 3.9 days, down 36.2% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The ratio has shown significant volatility over the period, ranging from 3.8 to 6.4 days.
CVSA Company Profile & Sector Positioning
Covista (CVSA) operates in the Education & Training Services industry within the broader Services-educational Services sector and is listed on the NYSE. In monthly performance, the stock ranks #3,001 among all tracked companies.